[Cite as http://purl.org/au-research/grants/nhmrc/384330]
Prof Rachelle Buchbinder
Prof Marissa Lassere
Prof Lyn March
Prof Christopher Reid
Brief description We plan to collect health information from Australian patients with arthritis to monitor the benefits and safety of new treatments. All patients being treated with the new injectable biologic agents and other patients taking conventional drugs will be invited to take part in the follow up program. We will measure the impact of arthritis on quality of life and physical function and the long-term effects of all arthritis drugs. This will be of immense value to the Australian community as this data are not routinely available from any other source. It will help rheumatologists and patients make the best decisions regarding long-term arthritis treatments.
Funding Amount $AUD 1,568,125.00
Funding Scheme NHMRC Enabling Grants